(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 5.09% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Sanofi's revenue in 2024 is $49,939,784,946.On average, 6 Wall Street analysts forecast SNY's revenue for 2024 to be $64,750,809,601,770, with the lowest SNY revenue forecast at $60,893,802,096,305, and the highest SNY revenue forecast at $67,642,375,054,099. On average, 6 Wall Street analysts forecast SNY's revenue for 2025 to be $68,939,374,300,709, with the lowest SNY revenue forecast at $65,313,514,048,779, and the highest SNY revenue forecast at $71,820,287,607,699.
In 2026, SNY is forecast to generate $73,354,698,662,091 in revenue, with the lowest revenue forecast at $69,396,693,084,701 and the highest revenue forecast at $76,001,273,625,224.